MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.660
Bid (Size) 4.500 (100)
Ask (Size) 4.820 (200)
Prev. Close 4.660
Today's Range 4.660 - 4.660
52wk Range 4.000 - 5.550
Shares Outstanding 223,988,675
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier
In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the... 
Via MarketMinute
News headline image
BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism
In a move that signals the end of an era for independent mRNA pioneers, BioNTech SE (Nasdaq: BNTX) has officially completed its acquisition of longtime rival CureVac N.V. (Nasdaq: CVAC). The... 
Via MarketMinute
Topics Intellectual Property

Performance

YTD
-0.2%
-0.2%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+8.1%
+8.1%
1 Year
-13.1%
-13.1%

More News

Read More
News headline image
CureVac Announces Voting Results of Extraordinary General Meeting
Via ACCESS Newswire
News headline image
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
Via ACCESS Newswire
News headline image
CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates
Via ACCESS Newswire
News headline image
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth ↗
Via Benzinga
News headline image
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma ↗
Via Stocktwits
News headline image
This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
Via Benzinga
News headline image
CureVac Announces Voting Results of General Meeting
Via ACCESS Newswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
5 Stocks To Ride The German Market Rally ↗
Via Benzinga
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗
Via Benzinga
News headline image
Market Monitor News June 13 (Oracle UP - Gamestop DOWN) ↗
Via Chartmill
Topics Artificial Intelligence Economy
News headline image
Here are the top movers in Thursday's session. ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results ↗
Via Benzinga
News headline image
BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal ↗
Via Benzinga
News headline image
CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday ↗
Via Benzinga
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment ↗
Via Stocktwits
News headline image
CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗
Via Benzinga
Topics Government

Frequently Asked Questions

Is CureVac N.V. - Ordinary Shares publicly traded?
Yes, CureVac N.V. - Ordinary Shares is publicly traded.
What exchange does CureVac N.V. - Ordinary Shares trade on?
CureVac N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for CureVac N.V. - Ordinary Shares?
The ticker symbol for CureVac N.V. - Ordinary Shares is CVAC on the Nasdaq Stock Market
What is the current price of CureVac N.V. - Ordinary Shares?
The current price of CureVac N.V. - Ordinary Shares is 4.660
When was CureVac N.V. - Ordinary Shares last traded?
The last trade of CureVac N.V. - Ordinary Shares was at 01/05/26 04:00 PM ET
What is the market capitalization of CureVac N.V. - Ordinary Shares?
The market capitalization of CureVac N.V. - Ordinary Shares is 1.04B
How many shares of CureVac N.V. - Ordinary Shares are outstanding?
CureVac N.V. - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story